What is the study?

The purpose of this study is to determine whether the psychedelic substance psilocybin changes brain activity in functional neurological disorder. We will measure this using functional magnetic resonance imaging (fMRI) before and after a single dose of psilocybin.

​

In doing this, we hope to better understand the brain activity signals seen in FND. Increased understanding may help to guide us to investigate new treatments in future.

​

The study has received ethical approval and will be conducted at King’s College London.

 

Can I take part?

We are actively seeking participants aged 25-60 who have a diagnosis of FND which has not responded to at least one form of recommended treatment.

​

You do not have to take part and if you decide not to your care and treatment will not be affected in any way.

 

How can I find out more?

For more information on the study, please email psifund@kcl.ac.uk. Alternatively, please follow the online link to fill out a short pre-screening questionnaire to be further considered by the research team.

 

Thank you for your interest in participating in the study